Literature DB >> 29725033

Constitutive activation of nuclear factor kappa B-inducing kinase counteracts apoptosis in cells with rearranged mixed lineage leukemia gene.

Maja Studencka-Turski1, Gunter Maubach1, Michael Hartmut Feige1, Michael Naumann2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29725033     DOI: 10.1038/s41375-018-0128-7

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  6 in total

Review 1.  Targeting NF-κB-Inducing Kinase (NIK) in Immunity, Inflammation, and Cancer.

Authors:  Kathryn M Pflug; Raquel Sitcheran
Journal:  Int J Mol Sci       Date:  2020-11-11       Impact factor: 5.923

2.  A20 undermines alternative NF-κB activity and expression of anti-apoptotic genes in Helicobacter pylori infection.

Authors:  Michelle C C Lim; Gunter Maubach; Anna M Birkl-Toeglhofer; Johannes Haybaeck; Michael Vieth; Mchael Naumann
Journal:  Cell Mol Life Sci       Date:  2022-01-28       Impact factor: 9.261

3.  USP48 and A20 synergistically promote cell survival in Helicobacter pylori infection.

Authors:  Phatcharida Jantaree; Supattra Chaithongyot; Olga Sokolova; Michael Naumann
Journal:  Cell Mol Life Sci       Date:  2022-08-01       Impact factor: 9.207

Review 4.  The Therapeutic Potential of Targeting NIK in B Cell Malignancies.

Authors:  Marco V Haselager; Eric Eldering
Journal:  Front Immunol       Date:  2022-07-12       Impact factor: 8.786

5.  Helicobacter pylori-induced reactive oxygen species direct turnover of CSN-associated STAMBPL1 and augment apoptotic cell death.

Authors:  Supattra Chaithongyot; Michael Naumann
Journal:  Cell Mol Life Sci       Date:  2022-01-23       Impact factor: 9.261

6.  TIFA has dual functions in Helicobacter pylori-induced classical and alternative NF-κB pathways.

Authors:  Gunter Maubach; Michelle C C Lim; Olga Sokolova; Steffen Backert; Thomas F Meyer; Michael Naumann
Journal:  EMBO Rep       Date:  2021-07-30       Impact factor: 8.807

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.